sr 95531 has been researched along with epidermal growth factor in 1 studies
| Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) | Studies (epidermal growth factor) | Trials (epidermal growth factor) | Recent Studies (post-2010) (epidermal growth factor) |
|---|---|---|---|---|---|
| 610 | 0 | 209 | 24,155 | 217 | 4,699 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altafini, C; Avossa, D; Bianchini, D; Bisson, G; Broccard, FD; Pastore, G; Pegoraro, S; Ruaro, ME; Torre, V | 1 |
1 other study(ies) available for sr 95531 and epidermal growth factor
| Article | Year |
|---|---|
Sequential steps underlying neuronal plasticity induced by a transient exposure to gabazine.
Topics: Action Potentials; Animals; Animals, Newborn; Cells, Cultured; Cluster Analysis; Electric Stimulation; Epidermal Growth Factor; Evoked Potentials; GABA Antagonists; Gene Expression Profiling; Gene Expression Regulation; Hippocampus; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neuronal Plasticity; Neurons; Nucleic Acid Synthesis Inhibitors; Oligonucleotide Array Sequence Analysis; Orphan Nuclear Receptors; Potassium Channels; Protein Kinase Inhibitors; Pyridazines; Rats; Rats, Wistar; RNA, Messenger; Signal Transduction; Time Factors | 2010 |